Early Phase 1 HER2 Clinical Trials

4 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–4 of 4 trials

Recruiting

Early Phase 1

HEAT Trial (HER2 Antibody Therapy With Lutetium-177)

Advanced Solid TumorsHER2 Gene Mutation

Radiopharm Theranostics, Ltd30 enrolled5 locationsNCT06824155

Recruiting

Early Phase 1

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Breast CancerHER2-positive Breast CancerLocally Advanced Breast Cancer+1 more

Alison Stopeck30 enrolled1 locationNCT06220214

Recruiting

Early Phase 1

Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer

HER2-Negative Breast CarcinomaAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+3 more

Emory University40 enrolled4 locationsNCT05464810

Recruiting

Early Phase 1

Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors

Pleural Effusion, MalignantPeritoneal Carcinoma MetastaticHER2 Positive Malignancies

Sichuan University18 enrolled1 locationNCT04684459